These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 746340)
1. Lecithin:cholesterol acyltransferase as a possible diagnostic tool in ischemic heart disease. Dobiásová M; Vondra K Scand J Clin Lab Invest Suppl; 1978; 150():129-33. PubMed ID: 746340 [TBL] [Abstract][Full Text] [Related]
2. Cholesterol turnover and risk factors for the development of coronary heart disease. Dobiásová M; Vondra K Czech Med; 1982; 5(1):16-28. PubMed ID: 7075390 [TBL] [Abstract][Full Text] [Related]
3. [Esterifying activity of the plasma in patients with ischemic heart disease]. Ozerova IN; Gerasimova EN; Maĭ FT; Kurdanov KhA Vopr Med Khim; 1984; 30(5):118-23. PubMed ID: 6528515 [TBL] [Abstract][Full Text] [Related]
4. Regulation of plasma lecithin:cholesterol acyltransferase in man. I. Increased activity in primary hypertriglyceridemia. Rose HG; Juliano J J Lab Clin Med; 1976 Jul; 88(1):29-43. PubMed ID: 180216 [TBL] [Abstract][Full Text] [Related]
5. Distribution of lecithin-cholesterol acyltransferase in normolipidemic and dyslipidemic plasma. Cheung MC Int J Clin Lab Res; 1993; 23(1):30-3. PubMed ID: 8477088 [TBL] [Abstract][Full Text] [Related]
6. Similar behaviour of lecithin:cholesterol acyltransferase and pseudocholinesterase in liver disease and hyperlipoproteinemia. Cucuianu M; Opincaru A; Tapalagă D Clin Chim Acta; 1978 Apr; 85(1):73-9. PubMed ID: 647966 [TBL] [Abstract][Full Text] [Related]
7. Lecithin:cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women. Sutherland WH; Temple WA; Nye ER; Herbison PG Atherosclerosis; 1979 Nov; 34(3):319-27. PubMed ID: 518742 [TBL] [Abstract][Full Text] [Related]
8. A study of carbohydrate and lipid metabolism in cases of hyperlipidemia and coronary heart disease. II. Preliminary observations on plasma lecithin cholesterol acyl transferase. Liu BW; Liu WZ; Wu ZF; Zhang RJ; Zhang Rongjue Chin Med J (Engl); 1979 Dec; 92(12):822-6. PubMed ID: 117986 [No Abstract] [Full Text] [Related]
9. Lecithin: cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia. Wallentin L Atherosclerosis; 1977 Feb; 26(2):233-48. PubMed ID: 189784 [TBL] [Abstract][Full Text] [Related]
12. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models. Ng DS Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749 [TBL] [Abstract][Full Text] [Related]
13. On the interpretation and potential diagnostic value of the measurements related to lecithin:cholesterol acyltransferase activity. Lacko AG Clin Biochem; 1976 Aug; 9(4):212-5. PubMed ID: 954185 [TBL] [Abstract][Full Text] [Related]
18. Decreased plasma lecithin:cholesterol acyltransfer and associated changes in plasma and red cell lipids in uraemia. Gillett MP; Teixeira V; Dimenstein R Nephrol Dial Transplant; 1993; 8(5):407-11. PubMed ID: 8393544 [TBL] [Abstract][Full Text] [Related]
19. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. Dullaart RP; Perton F; Sluiter WJ; de Vries R; van Tol A J Clin Endocrinol Metab; 2008 Dec; 93(12):4860-6. PubMed ID: 18782872 [TBL] [Abstract][Full Text] [Related]
20. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease. Nass KJ; van den Berg EH; Gruppen EG; Dullaart RPF Eur J Clin Invest; 2018 Sep; 48(9):e12988. PubMed ID: 29947103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]